Biocept reported $2.6M in Pre-Tax Profit for its first fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Abbott ABT:US $ 2469M 317M
Biocept BIOC:US $ 2.6M 0.7M
Celldex Therapeutics CLDX:US $ -16.54M 6.3M
Cerulean Pharma CERU:US $ -8.44M 0M
Cytori Therapeutics CYTX:US $ -2.72M 0.87M
Quest Diagnostics DGX:US $ 554M 120M
Thermo Fisher Scientific TMO:US $ 2573M 838M